{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T19:25:36Z","timestamp":1782761136932,"version":"3.54.5"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Pharmacology"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.coph.2015.08.005","type":"journal-article","created":{"date-parts":[[2015,8,28]],"date-time":"2015-08-28T05:30:14Z","timestamp":1440739814000},"page":"1-6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Gaseous mediator-based anti-inflammatory drugs"],"prefix":"10.1016","volume":"25","author":[{"given":"Oksana","family":"Sulaieva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John L","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coph.2015.08.005_bib0315","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1152\/physrev.00004.2008","article-title":"Prostaglandins NSAIDs, and gastric mucosal protection: why doesn\u2019t the stomach digest itself?","volume":"88","author":"Wallace","year":"2008","journal-title":"Physiol Rev"},{"key":"10.1016\/j.coph.2015.08.005_bib0320","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.3748\/wjg.v19.i12.1861","article-title":"Mechanisms, prevention and clinical implications of nonsteroidal anti-inflammatory drug-enteropathy","volume":"19","author":"Wallace","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.coph.2015.08.005_bib0325","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1053\/j.gastro.2011.06.075","article-title":"Proton pump inhibitors exacerbate NSAID-induced small intestinal injury by inducing dysbiosis","volume":"141","author":"Wallace","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coph.2015.08.005_bib0330","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/j.mayocp.2014.07.015","article-title":"Nonsteroidal anti-inflammatory drugs, proton pump inhibitors, and gastrointestinal injury: contrasting interactions in the stomach and small intestine","volume":"89","author":"Marlicz","year":"2014","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.coph.2015.08.005_bib0335","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1136\/bmj.332.7553.1302","article-title":"Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials","volume":"332","author":"Kearney","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.coph.2015.08.005_bib0340","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12916-015-0291-x","article-title":"Consensus about managing gastrointestinal and cardiovascular risks of nonsteroidal anti-inflammatory drugs?","volume":"13","author":"Yeomans","year":"2015","journal-title":"BMC Med"},{"key":"10.1016\/j.coph.2015.08.005_bib0345","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.cgh.2007.04.031","article-title":"Long-term effects of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 selective agents on the small bowel: a cross-sectional capsule enteroscopy study","volume":"5","author":"Maiden","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.coph.2015.08.005_bib0350","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1053\/gast.2000.16510","article-title":"NSAID-induced gastric damage in rats: requirement for inhibition of both cyclooxygenase 1 and 2","volume":"119","author":"Wallace","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coph.2015.08.005_bib0355","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1124\/pr.57.4.3","article-title":"Carbon monoxide: endogenous production, physiological functions, and pharmacological applications","volume":"57","author":"Wu","year":"2005","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.coph.2015.08.005_bib0360","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1111\/bph.12632","article-title":"CO and CO-releasing molecules (CO-RMs) in acute gastrointestinal inflammation","volume":"172","author":"Babu","year":"2015","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.coph.2015.08.005_sbref0365","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nrd4433","article-title":"Hydrogen sulfide-based therapeutics: exploiting a unique but ubiquitous gasotransmitter","volume":"14","author":"Wallace","year":"2015","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.coph.2015.08.005_bib0370","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0016-5085(94)90074-4","article-title":"Novel nonsteroidal anti-inflammatory drug derivatives with markedly reduced ulcerogenic properties in the rat","volume":"107","author":"Wallace","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coph.2015.08.005_sbref0375","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/j.1476-5381.2009.00611.x","article-title":"Markedly reduced toxicity of a hydrogen sulphide-releasing derivative of naproxen (ATB-346)","volume":"159","author":"Wallace","year":"2010","journal-title":"Br J Pharmacol"},{"issue":"Suppl. 1","key":"10.1016\/j.coph.2015.08.005_bib0380","doi-asserted-by":"crossref","first-page":"S193","DOI":"10.1038\/sj.bjp.0706458","article-title":"The discovery of nitric oxide and its role in vascular biology","volume":"147","author":"Moncada","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.coph.2015.08.005_bib0385","doi-asserted-by":"crossref","first-page":"G341","DOI":"10.1152\/ajpgi.2000.279.2.G341","article-title":"Endothelial nitric oxide synthase modulates gastric ulcer healing in rats","volume":"279","author":"Ma","year":"2000","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.coph.2015.08.005_bib0390","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/0016-5085(95)90341-0","article-title":"A nitric oxide-releasing nonsteroidal anti-inflammatory drug accelerates gastric ulcer healing in rats","volume":"109","author":"Elliott","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coph.2015.08.005_bib0395","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/sj.bjp.0707193","article-title":"Enhanced activity of a hydrogen sulphide-releasing derivative of mesalamine (ATB-429) in a mouse model of colitis","volume":"150","author":"Fiorucci","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.coph.2015.08.005_bib0400","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/sj.bjp.0704876","article-title":"Pharmacology and potential therapeutic applications of nitric oxide-releasing non-steroidal anti-inflammatory and related nitric oxide-donating drugs","volume":"137","author":"Keeble","year":"2002","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.coph.2015.08.005_bib0405","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1021\/jm030276s","article-title":"Synthesis and selective cyclooxygenase-2 inhibitory activity of a series of novel, nitric oxide donor-containing pyrazoles","volume":"47","author":"Ranatunge","year":"2004","journal-title":"J Med Chem"},{"key":"10.1016\/j.coph.2015.08.005_bib0410","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1136\/ard.2004.023572","article-title":"A randomised, placebo controlled, comparative trial of the gastrointestinal safety and efficacy of AZD3582 versus naproxen in osteoarthritis","volume":"64","author":"Lohmander","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.coph.2015.08.005_bib0415","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s12013-013-9791-5","article-title":"Non-steroidal anti-inflammatory drugs and hypertension","volume":"69","author":"Zheng","year":"2014","journal-title":"Cell Biochem Biophys"},{"key":"10.1016\/j.coph.2015.08.005_bib0420","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1136\/bjophthalmol-2014-305908","article-title":"A randomised, controlled comparison of latanoprostene bunod and latanoprost 0.005% in the treatment of ocular hypertension and open angle glaucoma: the VOYAGER study","volume":"99","author":"Weinreb","year":"2015","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.coph.2015.08.005_bib0425","doi-asserted-by":"crossref","first-page":"9438","DOI":"10.1167\/iovs.11-7839","article-title":"eNOS, a pressure-dependent regulator of intraocular pressure","volume":"52","author":"Stamer","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.coph.2015.08.005_bib0430","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.resp.2012.04.004","article-title":"Evolutionary and comparative aspects of nitric oxide, carbon monoxide and hydrogen sulfide","volume":"184","author":"Olson","year":"2012","journal-title":"Respir Physiol Neurobiol"},{"key":"10.1016\/j.coph.2015.08.005_sbref0435","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/ars.2011.4186","article-title":"Detoxification of H2S by differentiated colonic epithelial cells: implication of the sulfide oxidizing unit and of the cell respiratory capacity","volume":"17","author":"Mimoun","year":"2012","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.coph.2015.08.005_sbref0440","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1523\/JNEUROSCI.16-03-01066.1996","article-title":"The possible role of hydrogen sulfide as an endogenous neuromodulator","volume":"16","author":"Abe","year":"1996","journal-title":"J Neurosci"},{"key":"10.1016\/j.coph.2015.08.005_sbref0445","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1096\/fj.02-0211hyp","article-title":"Two's company, three's a crowd: can H2S be the third endogenous gaseous transmitter?","volume":"16","author":"Wang","year":"2002","journal-title":"FASEB J"},{"key":"10.1016\/j.coph.2015.08.005_sbref0450","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1096\/fj.06-6270fje","article-title":"Hydrogen sulfide is an endogenous modulator of leukocyte-mediated inflammation","volume":"20","author":"Zanardo","year":"2006","journal-title":"FASEB J"},{"key":"10.1016\/j.coph.2015.08.005_bib0455","doi-asserted-by":"crossref","first-page":"G467","DOI":"10.1152\/ajpgi.00169.2013","article-title":"Hydrogen sulfide-based therapeutics and gastrointestinal diseases: translating physiology to treatments","volume":"305","author":"Chan","year":"2013","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.coph.2015.08.005_bib0460","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1053\/j.gastro.2006.11.042","article-title":"Gastrointestinal safety and anti-inflammatory effects of a hydrogen sulfide-releasing diclofenac derivative in the rat","volume":"132","author":"Wallace","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coph.2015.08.005_bib0465","doi-asserted-by":"crossref","first-page":"e35196","DOI":"10.1371\/journal.pone.0035196","article-title":"Gastrointestinal-sparing effects of novel NSAIDs in rats with compromised mucosal defence","volume":"7","author":"Blackler","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.coph.2015.08.005_bib0470","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.niox.2014.11.010","article-title":"H2S-releasing drugs: anti-inflammatory, cytoprotective and chemopreventative potential","volume":"46","author":"Gemici","year":"2015","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.coph.2015.08.005_bib0475","doi-asserted-by":"crossref","first-page":"s25","DOI":"10.1161\/ATVBAHA.107.160481","article-title":"Aspirin: promise and resistance in the new millennium","volume":"28","author":"Patrono","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.coph.2015.08.005_bib0480","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa021633","article-title":"A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer","volume":"348","author":"Sandler","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coph.2015.08.005_bib0485","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1158\/1940-6207.CAPR-14-0018","article-title":"Aspirin other NSAIDs as chemoprevention agents in melanoma","volume":"7","author":"Goodman","year":"2014","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.coph.2015.08.005_bib0490","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s13402-014-0175-7","article-title":"Targeting epigenetic mechanisms and microRNAs by aspirin and other non steroidal anti-inflammatory agents \u2013 implications for cancer treatment and chemoprevention","volume":"37","author":"Yiannakopoulou","year":"2014","journal-title":"Cell Oncol (Dordr)"},{"key":"10.1016\/j.coph.2015.08.005_bib0495","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.niox.2014.04.006","article-title":"Enhanced chemopreventive effects of a hydrogen sulfide-releasing anti-inflammatory drug (ATB-346) in experimental colorectal cancer","volume":"41","author":"Elsheikh","year":"2014","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.coph.2015.08.005_sbref0500","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1089\/ars.2013.5308","article-title":"Anti-cancer activity of new designer hydrogen sulfide-donating hybrids","volume":"20","author":"Kashfi","year":"2014","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.coph.2015.08.005_bib0505","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.bbrc.2012.02.051","article-title":"NOSH-aspirin (NBS-1120), a novel nitric oxide- and hydrogen sulfide-releasing hybrid is a potent inhibitor of colon cancer cell growth in vitro and in a xenograft mouse model","volume":"419","author":"Chattopadhyay","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.coph.2015.08.005_bib0510","doi-asserted-by":"crossref","first-page":"4197","DOI":"10.1039\/b704873d","article-title":"CO and NO in medicine","author":"Mann","year":"2007","journal-title":"Chem Commun (Camb)"},{"key":"10.1016\/j.coph.2015.08.005_bib0515","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.tibs.2006.09.001","article-title":"CO-metal interaction: vital signaling from a lethal gas","volume":"31","author":"Boczkowski","year":"2006","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.coph.2015.08.005_sbref0520","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1042\/BST0351142","article-title":"Carbon monoxide-releasing molecules (CO-RMs): vasodilatory, anti-ischaemic and anti-inflammatory activities","volume":"35","author":"Motterlini","year":"2007","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.coph.2015.08.005_bib0525","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/2045-9912-2-28","article-title":"Emerging concepts on the anti-inflammatory actions of carbon monoxide-releasing molecules (CO-RMs)","volume":"2","author":"Motterlini","year":"2012","journal-title":"Med Gas Res"},{"key":"10.1016\/j.coph.2015.08.005_bib0530","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1089\/15230860260220111","article-title":"Regulation of heme oxygenase-1 by redox signals involving nitric oxide","volume":"4","author":"Motterlini","year":"2002","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.coph.2015.08.005_bib0535","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.freeradbiomed.2008.05.013","article-title":"Carbon monoxide, reactive oxygen signaling, and oxidative stress","volume":"45","author":"Piantadosi","year":"2008","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.coph.2015.08.005_sbref0540","doi-asserted-by":"crossref","first-page":"6378","DOI":"10.4049\/jimmunol.1202969","article-title":"Inhaled carbon monoxide accelerates resolution of inflammation via unique proresolving mediator-heme oxygenase-1 circuits","volume":"190","author":"Chiang","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.coph.2015.08.005_bib0545","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1039\/c3mt00117b","article-title":"The hexacarbonyldicobalt derivative of aspirin acts as a CO-releasing NSAID on malignant mesothelioma cells","volume":"5","author":"Zanellato","year":"2013","journal-title":"Metallomics"},{"key":"10.1016\/j.coph.2015.08.005_bib0550","doi-asserted-by":"crossref","first-page":"7674","DOI":"10.1073\/pnas.89.16.7674","article-title":"Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin","volume":"89","author":"Stamler","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coph.2015.08.005_bib0555","doi-asserted-by":"crossref","first-page":"R1479","DOI":"10.1152\/ajpregu.90566.2008","article-title":"Whole tissue hydrogen sulfide concentrations are orders of magnitude lower than presently accepted values","volume":"295","author":"Furne","year":"2008","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.coph.2015.08.005_bib0560","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1021\/tx050283e","article-title":"Threshold effects of nitric oxide-induced toxicity and cellular responses in wild-type and p53-null human lymphoblastoid cells","volume":"19","author":"Li","year":"2006","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.coph.2015.08.005_bib0565","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.tips.2007.09.003","article-title":"Hydrogen sulfide-releasing anti-inflammatory drugs","volume":"28","author":"Wallace","year":"2007","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.coph.2015.08.005_bib0570","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1056\/NEJMcp0808891","article-title":"Clinical practice. Carbon monoxide poisoning","volume":"360","author":"Weaver","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coph.2015.08.005_bib0575","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/320454a0","article-title":"Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor","volume":"320","author":"Gryglewski","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.coph.2015.08.005_bib0580","doi-asserted-by":"crossref","first-page":"9099","DOI":"10.3390\/molecules20059099","article-title":"Gaseous mediators nitric oxide and hydrogen sulfide in the mechanism of gastrointestinal integrity, protection and ulcer healing","volume":"20","author":"Magierowski","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.coph.2015.08.005_bib0585","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.bbrc.2004.02.176","article-title":"Impact of hydrogen sulfide on carbon monoxide\/heme oxygenase pathway in the pathogenesis of hypoxic pulmonary hypertension","volume":"317","author":"Qingyou","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.coph.2015.08.005_bib0590","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1111\/j.1745-7254.2006.00425.x","article-title":"Interaction between hydrogen sulfide\/cystathionine \u03b3-lyase and carbon monoxide\/heme oxygenase pathways in aortic smooth muscle cells","volume":"27","author":"Jin","year":"2006","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.coph.2015.08.005_bib0595","first-page":"F882","article-title":"Carbon monoxide induces vasodilation and nitric oxide release but suppresses endothelial NOS","volume":"277","author":"Thorup","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1016\/j.coph.2015.08.005_bib0600","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1586\/ecp.10.56","article-title":"Hydrogen sulfide-mediated myocardial pre- and post-conditioning","volume":"4","author":"Predmore","year":"2011","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.coph.2015.08.005_sbref0605","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1073\/pnas.1119658109","article-title":"Hypoxic regulation of the cerebral microcirculation is mediated by a carbon monoxide-sensitive hydrogen sulfide pathway","volume":"109","author":"Morikawa","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.coph.2015.08.005_bib0610","doi-asserted-by":"crossref","first-page":"10719","DOI":"10.1073\/pnas.1005866107","article-title":"H2S mediates O2 sensing in the carotid body","volume":"107","author":"Peng","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.coph.2015.08.005_bib0615","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.redox.2013.05.001","article-title":"A tale of two gases: NO and H2S, foes or friends for life?","volume":"1","author":"Kolluru","year":"2013","journal-title":"Redox Biol"},{"key":"10.1016\/j.coph.2015.08.005_bib0620","doi-asserted-by":"crossref","first-page":"e0121621","DOI":"10.1371\/journal.pone.0121621","article-title":"Interactions of the gasotransmitters contribute to microvascular tone (dys)regulation in the preterm neonate","volume":"10","author":"Dyson","year":"2015","journal-title":"PLOS ONE"}],"container-title":["Current Opinion in Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489215000983?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489215000983?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,21]],"date-time":"2022-05-21T01:46:00Z","timestamp":1653097560000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471489215000983"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":62,"alternative-id":["S1471489215000983"],"URL":"https:\/\/doi.org\/10.1016\/j.coph.2015.08.005","relation":{},"ISSN":["1471-4892"],"issn-type":[{"value":"1471-4892","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gaseous mediator-based anti-inflammatory drugs","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coph.2015.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}